Berman Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Berman Capital Advisors's AMGN Position: Q3 2021 in Review
Berman Capital Advisors reduced its Amgen (AMGN) stake by 8.2% in Q3 2021, selling an estimated $38K and leaving 1,850 shares worth $392K. The position accounts for 0.06% of the portfolio, ranked #162.
Berman Capital Advisors first reported a position in AMGN in Q4 2018 and has held it in 12 quarters since. The position peaked at $491K in Q2 2021. 2,132 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.
- Berman Capital Advisors held 1,850 shares of Amgen worth $392K as of Q3 2021.
- Berman Capital Advisors sold 165 Amgen shares in Q3 2021, an estimated $38K.
- Amgen made up 0.06% of Berman Capital Advisors's portfolio in Q3 2021, its #162 holding.
- Berman Capital Advisors first reported a position in Amgen in Q4 2018 and has held it in 12 quarters since.
- Berman Capital Advisors's Amgen position peaked at $491K in Q2 2021.
- 2,132 funds tracked by Wall St. Rank held Amgen as of Q3 2021.
Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.